Study for Opportunities Assessment for Hepatitis B Therapeutics in IndiaFrost & SullivanDecember 19, 2008 33 Pages - SKU: MC2065213 |
| Countries covered: India This research service aims to provide an update on the epidemiology of Hepatitis B, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the diabetes therapeutics market in India. |
More India Hepatitis Reports
Asian Vaccine Markets: India, China, Japan, Korea, Indonesia and Rest of Asia by
Kalorama Information
The Asian vaccine market is relatively small compared to its population, yet it is growing, and pharmaceutical manufacturers increasingly will look to boost sales from ...
See all reports like this >>
More India Reports
D&B Country RiskLine Report: India by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: India by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Country Report India January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
India: Country Profile by
MarketLine
INTRODUCTION This report provides a detailed analysis on India, providing an overview of its political, economic and business environment, represented both textually and in graph and ...
2007 India Industry & Market Outlook report by
Barnes Reports
The 2007 India Industry & Market Outlook report is the leading annual publication that describes over 100 major industries in India and 500+ minor industries ...
See all reports like this >>
Related Markets
Hepatitis Reports
- Chinese Markets for Hepatitis Drugs
- Liver Disease Treatments: The Global Market
- Hepatitis Market to 2017 - Strong Hepatitis-C Pipeline, Large Number of Strategic Consolidations and Cost Effective Treatments will Drive the Market
- Hepatitis B Vaccines - Pipeline Assessment and Market Forecasts to 2018
- Hepatitis C Global Clinical Trials Review, H2, 2011

